Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: Desmoglein 2 and desmocollin 2 depletions promote malignancy through distinct mechanisms in triple-negative and luminal breast cancer

Fig. 2

The protein levels of Dsg2 and Dsc2 were decreased in BC tissues and cell lines. (A) Protein expressions of Dsg2 and Dsc2 in 30 paired BC and adjacent normal tissues analyzed by IHC; T (Tumor), N (Normal). Scale bar represents 50 μm. (B) Protein expressions of Dsg2 and Dsc2 in BC cell lines and non-tumorigenic human breast MCF10A cells, GAPDH as the loading control. Data are presented as mean ± SD from three separate experiments. *indicates P < 0.05

Back to article page